Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 16, 2024
Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up studyRobin Willixhofer, René Rettl, Christina Kronberger, et al.Journal of Personalized Medicine|June 2, 2021
Renin Feedback Is an Independent Predictor of Outcome in HFpEFChristina Binder, Marko Poglitsch, Franz Duca, et al.Journal of Clinical Medicine|November 18, 2020
What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection FractionRené Rettl, Theresa-Marie Dachs, Franz Duca, et al.Journal of Clinical Medicine|December 23, 2020
Sex Differences in Left Ventricular Remodeling and Outcomes in Chronic Aortic RegurgitationAndreas A Kammerlander, Carolina Donà, Christian Nitsche, et al.JACC. Cardiovascular Imaging|March 18, 2019
Determinants of Bioprosthetic Aortic Valve DegenerationChristian Nitsche, Andreas A Kammerlander, Klaus Knechtelsdorfer, et al.Journal of Cardiac Failure|September 1, 2025
Amyloid-specific medication in transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis of cardiovascular outcome trialsMaximilian Autherith, Laurenz Hauptmann, Sophia Koschatko, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2020
Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosisChristina Binder, Franz Duca, Thomas Binder, et al.European Heart Journal. Cardiovascular Imaging|March 7, 2023
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathyRené Rettl, Tim Wollenweber, Franz Duca, et al.JACC. Cardiovascular Imaging|November 19, 2018
Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic RegurgitationAndreas A Kammerlander, Matthias Wiesinger, Franz Duca, et al.Scientific Reports|May 4, 2026
Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathyMahshid Eslami, Nikita Ermolaev, Christina Kronberger, et al.Pageof 9